Ernexa Therapeutics Inc. Property, Plant and Equipment, Gross
Ernexa Therapeutics Inc. (ERNA) had Property, Plant and Equipment, Gross of $291.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-13
- 2025-12-31: Property, Plant and Equipment, Gross $291.00K.
- 2024-12-31: Property, Plant and Equipment, Gross $257.00K.
- 2023-12-31: Property, Plant and Equipment, Gross $607.00K.
- 2022-12-31: Property, Plant and Equipment, Gross $268.00K.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $291.00K 10-K · filed 2026-03-13 | |
| 2024-12-31 | $257.00K 10-K · filed 2026-03-13 | |
| 2023-12-31 | $607.00K 10-K · filed 2025-03-12 | |
| 2022-12-31 | $268.00K 10-K · filed 2024-03-14 | |
| 2021-12-31 | $877.00K 10-K · filed 2023-03-20 | |
| 2021-03-31 | $714.34K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $714.00K 10-K/A · filed 2022-07-01 | $9.25M 10-K · filed 2021-03-11 |
| 2019-12-31 | $11.99M 10-K · filed 2021-03-11 | |
| 2018-12-31 | $15.17M 10-K · filed 2020-03-19 | |
| 2017-12-31 | $14.00M 10-K · filed 2019-03-22 | |
| 2016-12-31 | $14.09M 10-K · filed 2018-03-09 | |
| 2015-12-31 | $16.37M 10-K · filed 2017-03-09 | |
| 2014-12-31 | $22.74M 10-K · filed 2016-03-15 | |
| 2013-12-31 | $21.60M 10-K · filed 2015-03-27 | $21.46M 10-K · filed 2014-03-31 |
| 2012-12-31 | $21.60M 10-K · filed 2014-03-31 | |
| 2011-12-31 | $22.77M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |